Hjem › Overvægt
Overvægt kliniske forsøg rekrutterer i USA
205 studier for Overvægt rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- San Antonio, TX34 studier
- Houston, TX33 studier
- Chicago, IL28 studier
- Orlando, FL27 studier
- Las Vegas, NV23 studier
- Miami, FL23 studier
- Atlanta, GA20 studier
- Dallas, TX20 studier
- New York City, NY19 studier
- Jacksonville, FL19 studier
- Washington, DC19 studier
- Austin, TX18 studier
- Baltimore, MD17 studier
- Havelock, NC17 studier
- Birmingham, AL16 studier
- Concord, CA16 studier
- St. Louis, MO16 studier
- Los Angeles, CA15 studier
- Tucson, AZ15 studier
- Charlotte, NC15 studier
- Phoenix, AZ15 studier
- Louisville, KY15 studier
- Philadelphia, PA14 studier
- Johns Creek, GA14 studier
- Cincinnati, OH14 studier
- Columbus, OH13 studier
- Salt Lake City, UT13 studier
- San Diego, CA13 studier
- Indianapolis, IN13 studier
- Rochester, NY13 studier
- Escondido, CA12 studier
- Boston, MA12 studier
- Greensboro, NC12 studier
- Wilmington, NC11 studier
- Arlington, VA11 studier
- South Fulton, GA11 studier
- Grand Prairie, TX11 studier
- Honolulu, HI11 studier
- Farmington Hills, MI10 studier
- Nashville, TN10 studier
Efter delstat
- Alabama31 studier
- Arizona29 studier
- Arkansas6 studier
- Californien64 studier
- Colorado11 studier
- Connecticut16 studier
- District of Columbia7 studier
- Florida55 studier
- Georgia36 studier
- Hawaii11 studier
- Idaho19 studier
- Illinois38 studier
- Indiana16 studier
- Iowa9 studier
- Kansas26 studier
- Kentucky21 studier
- Louisiana23 studier
- Maryland37 studier
- Massachusetts24 studier
- Michigan19 studier
- Minnesota13 studier
- Mississippi11 studier
- Missouri34 studier
- Montana6 studier
- Nebraska7 studier
- Nevada24 studier
- New Hampshire3 studier
- New Jersey16 studier
- New Mexico4 studier
- New York45 studier
- North Carolina40 studier
- North Dakota8 studier
- Ohio35 studier
- Oklahoma18 studier
- Oregon13 studier
- Pennsylvania32 studier
- Rhode Island13 studier
- South Carolina35 studier
- South Dakota4 studier
- Tennessee25 studier
- Texas55 studier
- Utah22 studier
- Virginia33 studier
- Washington23 studier
- Wisconsin8 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07752979Effects of Pistachios on Postprandial Metabolic Responses in Adults With Overweight or Obesity
Rekrutterer
Alder 18 til 35 · Alle køn · Opdateret 2. okt. 2026 · NCT07853898A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 70 · Alle køn · Opdateret 2. okt. 2026 · NCT07675590Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
Rekrutterer
Alder 18 til 60 · Alle køn · Opdateret 2. okt. 2026 · NCT07641361Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
RekruttererFase 2Frivillige med god helbredstilstand velkomne
Alder 18 til 60 · Kvinder · Opdateret 2. okt. 2026 · NCT03407079Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Rekrutterer
Alder 21 til 65 · Alle køn · Opdateret 1. okt. 2026 · NCT07090005A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 85 · Alle køn · Opdateret 1. okt. 2026 · NCT07793929Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 til 35 · Alle køn · Opdateret 30. sep. 2026 · NCT07849439AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RekruttererFase 3
Alder 8 til 18 · Alle køn · Opdateret 30. sep. 2026 · NCT07253285FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT06724406A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07823608Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07685808Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 28. sep. 2026 · NCT07837973AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07720271Physical and Behavioral Traits of Overweight and Obese Adults
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT00428987Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 28. sep. 2026 · NCT07399678A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07668414A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07776509Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07594093Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.